DK0831835T3 - Behandling af anorexia - Google Patents

Behandling af anorexia

Info

Publication number
DK0831835T3
DK0831835T3 DK96920403T DK96920403T DK0831835T3 DK 0831835 T3 DK0831835 T3 DK 0831835T3 DK 96920403 T DK96920403 T DK 96920403T DK 96920403 T DK96920403 T DK 96920403T DK 0831835 T3 DK0831835 T3 DK 0831835T3
Authority
DK
Denmark
Prior art keywords
anorexia
treatment
methyl
benzodiazepine
thieno
Prior art date
Application number
DK96920403T
Other languages
Danish (da)
English (en)
Inventor
Charles M Beasley Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0831835T3 publication Critical patent/DK0831835T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Soil Working Implements (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Manufacturing Of Magnetic Record Carriers (AREA)
  • Fish Paste Products (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK96920403T 1995-06-01 1996-05-23 Behandling af anorexia DK0831835T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45724995A 1995-06-01 1995-06-01
PCT/US1996/007467 WO1996038152A1 (fr) 1995-06-01 1996-05-23 Methode de traitement de l'anorexie

Publications (1)

Publication Number Publication Date
DK0831835T3 true DK0831835T3 (da) 2002-11-25

Family

ID=23815994

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920403T DK0831835T3 (da) 1995-06-01 1996-05-23 Behandling af anorexia

Country Status (10)

Country Link
EP (1) EP0831835B1 (fr)
JP (1) JPH08325151A (fr)
AT (1) ATE226825T1 (fr)
AU (1) AU5872596A (fr)
CA (1) CA2222073A1 (fr)
DE (1) DE69624566T2 (fr)
DK (1) DK0831835T3 (fr)
ES (1) ES2185777T3 (fr)
PT (1) PT831835E (fr)
WO (1) WO1996038152A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
JP4503826B2 (ja) * 1997-09-30 2010-07-14 イーライ リリー アンド カンパニー ２−メチル−チエノ−ベンゾジアゼピン製剤
US6395727B1 (en) 1999-03-18 2002-05-28 The Cincinnati Children's Hospital Research Foundation Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications
ES2363364T3 (es) 2005-01-05 2011-08-02 Eli Lilly And Company Dihidrato de pamoato de olanzapina.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250571A (en) * 1988-11-14 1993-10-05 Eli Lilly And Company (S)-norfluoxetine in method of inhibiting serotonin uptake
US5234945A (en) * 1989-05-09 1993-08-10 Whitby Research, Inc. Method of producing body weight and food intake using a dopamine D2 receptor agonist
US5250572A (en) * 1990-03-29 1993-10-05 Eli Lilly And Company (R)-norfluoxetine in method for occupying serotonin IC receptors
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
WO1993002678A1 (fr) * 1991-08-09 1993-02-18 Merrell Dow Pharmaceuticals Inc. Utilisation de derives de quinoziline en tant qu'orexigenes
GB9306460D0 (en) * 1993-03-29 1993-05-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP0831835A1 (fr) 1998-04-01
PT831835E (pt) 2003-01-31
DE69624566D1 (de) 2002-12-05
WO1996038152A1 (fr) 1996-12-05
ES2185777T3 (es) 2003-05-01
JPH08325151A (ja) 1996-12-10
DE69624566T2 (de) 2003-06-26
EP0831835A4 (fr) 2000-03-01
CA2222073A1 (fr) 1996-12-05
EP0831835B1 (fr) 2002-10-30
ATE226825T1 (de) 2002-11-15
AU5872596A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
HUP9802824A3 (en) Novel crystal form of the 2-methyl-4-(4-methyl-1-piprezinyl)-10h-thieno[2,3-b][1,5]benzodiazepine and process for its preparation
IL117971A0 (en) Method for treating dyskinesias
MX9805064A (es) Uso de 2-metil-4-(4-metil-1-piperazinil)-1oh-tieno[2,3-b][1,5]benzo diazepina.
NZ332037A (en) Olanzapine for treating migraine pain
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
DK0831835T3 (da) Behandling af anorexia
EP0911028A3 (fr) Methode por le traitement de la disfonctionnement sexuelle
MX9707936A (es) Compuestos para tratar disfunciones del conocimiento.
PL331321A1 (en) Treatment pf psychotic disorders
IL126158A0 (en) Method for treating substance abuse
IL126157A0 (en) Method for treating excessive aggression
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
NZ331846A (en) Method for preparing a medicament using olanzapine for treating insomnia
MX9706825A (es) El uso farmacologico de ciertos derivados de cistina.